United Therapeutics (UTHR) Tops Q1 EPS by 32c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $497.97 +2.12%
EPS Growth %: -10.1%
Financial Fact:
Total other (expense) income, net: 500K
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -10.1%
Financial Fact:
Total other (expense) income, net: 500K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $4.86, $0.32 better than the analyst estimate of $4.54. Revenue for the quarter came in at $506.9 million versus the consensus estimate of $512.69 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- BMO Capital Starts Carter's (CRI) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
